db take bard accret target line prior commun guidanc
appear achiev conserv view
bd sale ep ahead factset estim estim
expect becton updat scal guidanc includ bard
acquisit believ guidanc appear achiev
conserv volatil market believ share go-to stock
reiter buy rate updat ep estim
better reect inclus bard fx intend invest spend
futur revenu synergi initi revis ep estim
respect maintain price target updat
target multipl pe previous calendar ep
slight premium current med-tech averag pe trail ep
believ warrant given stabil growth
takeaway quarter call
becton perform better expect tough
comparison revenu currenc neutral basi
exclud impact us dispens revenu recognit
account chang revenu sever season
ad top line price neg
quarter revenu ahead consensu expect ep
bard revenu perform line guidanc becton
comment bard grew constant currenc sale
quarter includ bp impact hurrican maria thu
adjust impact hurrican quarter underli sale
growth line compani prior guidanc sale
growth also impact suppli constraint progel
expect persist throughout cours scal
guidanc updat bard expect becton provid
rst time ocial guidanc follow close bard acquisit
accret estim line manag prior commentari
believ new guidanc rang achiev strike
us somewhat conserv well said extent
upsid driver believ manag like partial reinvest back
busi
becton expect grow one
price feb usd
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
exclud dispens chang hurrican impact becton
continu expect base revenu growth rang
includ headwind due us
dispens revenu recognit chang expect bard busi
deliv revenu growth includ
headwind hurrican maria
ep guidanc becton rais ep guidanc stand-alon
basi incorpor
impact bard accret divestitur time
 recent fx movement
manag reiter bard target becton continu expect low
singl digit accret year one high singl digit accret
year two achiev million cost synergi
becton also reiter goal return leverag
higher resin expens offset flu benefit track
today stronger rel year ago manag comment
expect translat upsid compani go forward
last year strong late season moreov benet
would oset higher resin cost becton note resin cost
expect increment million higher previous
smart pen put back burner favor swatch patch
manag note go stop eort
dose captur smart needl technolog focu diabet eort
patch pump technolog time patch pump year
end scal patch smart patch technolog
iv solut ship becton began ship iv solut custom
though compani would provid specic comment
specic capac partner freseniu
say line expect becton note
continu work freseniu long-term capac plan
serv market
lutonix opportun growth ahead becton continu see
growth opportun acquir lutonix drug-coat balloon
becton note av access dcb launch begin
rst quarter januari compani complet enrol below-
the-kne btk studi expect complet month follow-up
submit pma fda end calendar year
forecast ratio
takeawaysvari analysi surpris product sale mrptdcomp fxnbd mgmnt procedur life exclud impact divestituresbdx gener total sale factset fs dbe compar constant currenc basi sale increas includ advers impact us dispens busi model chang geographi us sale ou emerg market china compar fxn basi ep fs dbe addit detail quarter million except per share data chang sale constant currenc basi unless otherwis note posit changefi fiscal revenu expect grow ical segment revenu expect grow life scienc revenu expect grow intervent revenu expect grow fiscal ep expect rang repres net accret acquisit total sale report basi compar constant currenc basi exclud impact us dispens chang geographi us sale ou compar constant currenc basi includ emerg market gross margin y/i driven continu improv initi cost synergi favor mix includ posit impact divestitur well fx ssg margin increas margin flat y/i oper margin adjust tax rate share count y/i adjust ep report basi higher expect resin price like off-set benefit strong flu season revenu ep beat street consensu dbe manag increas life scienc revenu guidanc continu strength emerg market revenu manag reiter prior financi target relat bard transact quick recapmix februari
complet acquisit bard decemb
ad onto portfolio adjac posit intervent
medic product reorgan three medic
unit bd medic bd lifesci newli establish bd intervent
mostli legaci bard busi though legaci bd sale
becton state strateg rational turn includ point
deliv innov healthcar solut improv clinic
creat new opportun built bd leadership posit
medic manag infect prevent expand
oer solut across care continuum
increas bd opportun fast-grow clinic area includ
peripher vascular therapi oncolog biosurgeri
acceler combin compani growth outsid unit
creat nancial compel combin immedi low-singl
digit accret year one high-singl digit accret scal year
meaning long-term valu sharehold longer term
agre point believ acquisit bard though
complet full valuat one deliv long-term nancial valu
sharehold
frame bard
becton dickinson provid rst time ocial guidanc follow
close bard acquisit
becton expect grow one exclud
dispens chang hurrican impact becton continu
expect base revenu growth rang
includ headwind due us dispens revenu recognit
chang expect bard busi deliv revenu growth
includ headwind hurrican maria
ep guidanc becton rais ep guidanc stand-alon
basi bridg get new
guidanc follow
posit bard accret line prior commentari
low singl digit accret
neg divestitur time close recal deal close
decemb view slightli later
plan
posit lower tax rate relat tax reform legisl
impact outlook combin entiti
neg revenu synergi invest believ
money well spent
posit increment fx
believ new guidanc rang achiev strike us
somewhat conserv well said extent upsid driver
believ manag like partial reinvest back busi
sep incom statementtot profit ex profit margin incom incom net incom average year adjust epsamort per average februari
